We serve Chemical Name:2-(2H7)Propyl(2H8)pentanoic acid CAS:362049-65-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(2H7)Propyl(2H8)pentanoic acid
CAS.NO:362049-65-8
Synonyms:2-(H)Propyl(H)pentanoic acid;Pentanoic-2,3,3,4,4,5,5,5-d acid, 2-(propyl-d)-
Molecular Formula:C8HD15O2
Molecular Weight:159.304
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:220.0±0.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.435
PSA:37.30000
Exact Mass:159.209183
LogP:2.72
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(H)Propyl(H)pentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pentanoic-2,3,3,4,4,5,5,5-d acid, 2-(propyl-d)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(H)Propyl(H)pentanoic acid Use and application,2-(H)Propyl(H)pentanoic acid technical grade,usp/ep/jp grade.
Related News: They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. 2-(2H7)Propyl(2H8)pentanoic acid manufacturer The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 2-(2H7)Propyl(2H8)pentanoic acid supplier What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL. 2-(2H7)Propyl(2H8)pentanoic acid vendor The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 2-(2H7)Propyl(2H8)pentanoic acid factory The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.